Economic Burden of Chronic Obstructive Pulmonary Disease Patients in Malaysia: A Longitudinal Study

Abstract

Background Chronic obstructive pulmonary disease (COPD) requires long-term pharmacological and non-pharmacological management that encompasses continuous economic burden on patients and society, and also results in productivity losses due to compromised quality of life. Among working-age patients, COPD is the 11th leading cause of work productivity loss. Objective The aim of this study was to assess the economic burden of COPD in Malaysia, including direct costs for the management of COPD and indirect costs due to productivity losses for COPD patients. Methodology Overall, 150 patients with an established diagnosis of COPD were followed-up for a period of 1 year from August 2018 to August 2019. An activity-based costing, 'bottom-up' approach was used to calculate direct costs, while indirect costs of patients were assessed using the Work Productivity and Activity Impairment Questionnaire. Results The mean annual per-patient direct cost for the management of COPD was calculated as US$506.92. The mean annual costs per patient in the management phase, emergency department visits, and hospital admissions were reported as US$395.65, US$86.4, and US$297.79, respectively; 31.66% of COPD patients visited the emergency department and 42.47% of COPD patients were admitted to the hospital due to exacerbation. The annual mean indirect cost per patient was calculated as US$1699.76. Productivity losses at the workplace were reported as 31.87% and activity limitations were reported as 17.42%. Conclusion Drugs and consumables costs were the main cost-driving factors in the management of COPD. The higher ratio of indirect cost to direct medical costs shows that therapeutic interventions aimed to prevent work productivity losses may reduce the economic burden of COPD.

Validation and clinical interpretation of the St George’s respiratory questionnaire for COPD (SGRQ-C) after adaptation to Malaysian language and culture, in patients with COPD

“…The number of patients included in "test-retest reliability" test was according to the above-mentioned recommendation. The mean age reported in the study is bit higher, but it is in line with the previously published research on COPD in Malaysia [46]. The study was single centered, so the results should be generalized with caution.…”

Risk Factors Associated With Medication Errors Among Patients Suffering From Chronic Disorders

“…Chronic diseases cause substantial economic burden and are major causes of morbidity and mortality (18)(19)(20). Two-third of the chronic disease patients are older than 60 years, suffer from different comorbidities, and are on polypharmacy (five or more drugs) (21).…”

Assessment of risk factors responsible for rapid deterioration of lung function over a period of one year in patients with chronic obstructive pulmonary disease

“…Exacerbation causes deterioration of COPD symptoms increase the risk of mortality and is associated with substantial economic burden on healthcare system 35 – 37 . Thus, prevention of exacerbation is a key goal in the management of COPD 6 .…”